|
National Institute on Drug Abuse (NIDA)
http://www.nida.nih.gov/
A respected scientific research institution that studies and disseminates information on drug abuse and addiction prevention, treatment, and policy.
|
InfoFacts: LSD
Provides information on LSD (acid), including health hazards and extent of use.
|
InfoFacts: PCP
Provides information on PCP, including health hazards and extent of use.
|
Partnership Attitude Tracking Study (PATS): Teens 2003
Surveys adolescent use, attitudes and exposure to marijuana, Ecstasy, inhalants, methamphetamine, heroin, cocaine, LSD, alcohol and tobacco, as well as anti-drug media campaign messages. (Adobe Acrobat File)
|
Partnership Attitude Tracking Study (PATS): Parents 2003
Surveys parental assumptions and attitudes regarding drugs and today’s youth, as well as how parents handle the issue of drugs with their children. (Adobe Acrobat File)
|
Partnership Attitude Tracking Studies (1997-2003)
Connects to a list of all Partnership Attitude Tracking Studies from 1997 to 2003.
|
 |
|
Office of National Drug Control Policy (ONDCP)
http://www.whitehousedrugpolicy.gov/
Establishes policies, priorities and objectives for the Nation's drug control program.
|
Drug Facts: LSD
Links to federally-sponsored publications containing information about LSD(acid), including prevalence estimates, consequences of use, ajudication, and trafficking.
|
Drug Information: LSD Gives a brief overview of LSD (acid).
|
National Results on Adolescent Drug Use 2003
This annual survey of 8th, 10th, and 12th graders tracks trends in the use of licit and illict drugs as well as trends in the levels of perceived risk and personal disapproval associated with each drug. (Adobe Acrobat File) |
National Survey Results on Drug Use, 1975-2003, Volume I: Secondary School Students
This monograph gives the 1975-2003 national trends in smoking, drinking, and illicit drug use among American secondary school students. (Adobe Acrobat File) |
Hallucinogens: Drug Information
Includes information on the prevalence of use and physical/mental effects associated with hallucinogens.
|
Drug Intelligence Brief: Club Drugs, An Update (September 2001)
An in depth report on hallucinogens and other club drugs. Discusses MDMA (Ecstasy), ketamine, GHB, GBL, Rohypnol®, LSD, methamphetamine, PCP, Nexus, Psilocybin mushrooms, and 4-MTA.
|
Drug Intelligence Brief, Drug Alert: The Hallucinogen PMA: Dancing With Death (October 2000)
Discusses the history, availability, abuse, health effects, and trafficking (production/distribution) of PMA. (Adobe Acrobat file)
|
Lysergic Acid Diethylamide (LSD): Drug Information Includes information on the physical/mental effects and trafficking/production associated with LSD.
|
Peyote and Mescaline: Drug Information Provides a brief overview of peyote and mescaline.
|
Phencyclidine (PCP) & Related Drugs: Drug Information Includes information on the physical/mental effects and trafficking/production associated with PCP.
|
Psilocybin, Psilocyn and other Tryptamines: Drug Information Provides a brief overview of the hallucinogens Psilocybin, Psilocyn and other Tryptamines.
|
National Drug Threat Assessment 2004 (April 2004)
The most recently collected data from national law enforcement, intelligence and public health agencies. Includes information about the trafficking and abuse of hallucinogens. (Adobe Acrobat File)
|